Trials / Conditions / Advanced Lung Adenocarcinoma
Advanced Lung Adenocarcinoma
4 registered clinical trials studyying Advanced Lung Adenocarcinoma — 3 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Study of Bemcentinib Plus Pacritinib In Patients With Advanced Lung Adenocarcinoma NCT06516887 | The University of Texas Health Science Center at San Antonio | Phase 1 / Phase 2 |
| Recruiting | Defactinib, Avutometinib and Nivolumab for the Treatment of Anti-PD1 Refractory LKB1-Mutant Advanced Non-Small NCT06495125 | Emory University | Phase 2 |
| Recruiting | CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Pati NCT05733000 | Northwestern University | Phase 2 |
| Completed | Prophylactic TCM for Mitigation of EGFR-TKI Related Dermatological Adverse Effect NCT05204758 | China Medical University Hospital | Phase 3 |